(Q37692820)

22 August 2017

1 reference

title

Environmental factors and their timing in adult-onset multiple sclerosis (English)

1 reference

22 August 2017

0 references

2

Gavin Giovannoni

1 reference

22 August 2017

Adam E Handel

1

1 reference

22 August 2017

George C Ebers

series ordinal

3

1 reference

22 August 2017

Sreeram V Ramagopalan

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

16 February 2010

1 reference

22 August 2017

published in

Nature Reviews Neurology

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

156-166

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2010.1

22 August 2017

exact match

0 references

cites work

Risk of Multiple Sclerosis Related to Age at Immigration to Israel

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

EPIDEMIOLOGIC STUDY OF MULTIPLE SCLEROSIS IN ISRAEL. I. AN OVERALL REVIEW OF METHODS AND FINDINGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Epstein-Barr Virus Antibodies in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Children and smoking: the family circle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Geographic variation of MS incidence in two prospective studies of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

New concepts in the immunopathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Genes for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The worldwide prevalence of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Twin concordance and sibling recurrence rates in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Differential twin concordance for multiple sclerosis by latitude of birthplace

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Environmental factors and multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Environmental risk factors for multiple sclerosis. Part I: The role of infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Pediatric multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Parent-child concordance in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Maternal Transmission of Multiple Sclerosis in a Dutch Population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Parent-of-origin effect in multiple sclerosis: observations in half-siblings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Parent-of-origin effects in MS: observations from avuncular pairs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Parent-of-origin effect in multiple sclerosis: observations from interracial matings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Timing of birth and risk of multiple sclerosis: population based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The causal cascade to multiple sclerosis: a model for MS pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Age of onset in siblings concordant for multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Age of puberty and the risk of multiple sclerosis: a population based study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Genetic variation in LIN28B is associated with the timing of puberty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Natural history of multiple sclerosis: a unifying concept

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The epidemiology of autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Monthly ambient sunlight, infections and relapse rates in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Vitamin D insufficiency common in newborns, children and pregnant women living in Newfoundland and Labrador, Canada

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

HLA-DRB1 and month of birth in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Prenatal and perinatal factors and risk of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Gestational Diabetes and Multiple Sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Epidemiological study of multiple sclerosis in western Poland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Immunomodulatory effects of Vitamin D in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Occupational exposure to UV light and mortality from multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

A role of late Epstein-Barr virus infection in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Exposure to infant siblings during early life and risk of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Multiple sclerosis after infectious mononucleosis: record linkage study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Multiple Sclerosis After Infectious Mononucleosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Selective association of multiple sclerosis with infectious mononucleosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Multiple sclerosis and age at infection with common viruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Multiple sclerosis and antecedent infections: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The case for rhinoviruses in the pathogenesis of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Epstein-Barr virus and disease activity in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Clinical viral infections and multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Maternal smoking during pregnancy and multiple sclerosis amongst offspring.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Cigarette smoking and the progression of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Smoking is a risk factor for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Oral contraceptives and reproductive factors in multiple sclerosis incidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Cigarette smoking and incidence of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Smoking and disease progression in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Temporal trends in the incidence of multiple sclerosis: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Interactive effect of estradiol and vitamin D receptor gene polymorphisms as a possible determinant of growth in male and female infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

A timing-of-birth effect on multiple sclerosis clinical phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The urgent need to recommend an intake of vitamin D that is effective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Safety of vitamin D3 in adults with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Epstein-Barr virus-recent advances

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Vitamin D3-implications for brain development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Axon loss in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Sex-specific, male-line transgenerational responses in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Recent use of oral contraceptives and the risk of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Pregnancy and multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Oral contraceptives and the incidence of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The premenstrual period and exacerbations in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Sex differences in autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The role of sex steroids and gonadectomy in the control of thymic involution.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

The enemy within: keeping self-reactive T cells at bay in the periphery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Is there a case for a virus aetiology in multiple sclerosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Organic solvents and multiple sclerosis: a synthesis of the current evidence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Alcohol and mortality in middle-aged men from eastern France

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Organic solvents and the risk of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Cerebrospinal fluid cells and proteins in patients occupationally exposed to organic solvents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Distribution and mortality time trend of multiple sclerosis and some other diseases in Norway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Vitamin D status of middle-aged women at 65-71 degrees N in relation to dietary intake and exposure to ultraviolet radiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Vitamin D status in a rural population of northern Norway with high fish liver consumption

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.1

Demyelination: the role of reactive oxygen and nitrogen species.

31 March 2020

1 reference

12 December 2020

The Danish Multiple Sclerosis Registry: a 50-year follow-up.

1 reference

12 December 2020

The influence of oral contraceptives on the risk of multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis and organic solvents.

1 reference

12 December 2020

Epstein-Barr virus reactivation and multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2010.1

1 reference

Dimensions Publication ID

22 August 2017

1050731531

0 references

1 reference